Displaying 1-8 of 8 result(s).
| Board Name | Posts By Ernesto C | Post Created |
|---|---|---|
| IPIX Innovation Pharmaceuticals Inc | I don't disagree with you one bit. | 05/09/2018 11:19:22 AM |
| IPIX Innovation Pharmaceuticals Inc | Bottom line to me is that the FUDst | 05/09/2018 8:48:51 AM |
| IPIX Innovation Pharmaceuticals Inc | Looks like the team has wrung out e  (3) | 05/09/2018 8:23:25 AM |
| IPIX Innovation Pharmaceuticals Inc | Bravo, Pete! All of us armchair QBs (3) | 05/08/2018 10:35:25 PM |
| IPIX Innovation Pharmaceuticals Inc | We know a rat when we smell one. An | 05/08/2018 8:23:58 PM |
| IPIX Innovation Pharmaceuticals Inc | Nobody is going bankrupt. Leo can p (1) | 05/08/2018 6:41:12 PM |
| IPIX Innovation Pharmaceuticals Inc | We have been saying this quarter af | 05/07/2018 9:39:30 PM |
| IPIX Innovation Pharmaceuticals Inc | Great post Pete. Any way you slice (2) | 05/07/2018 6:06:49 PM |
Recent Articles
- SCO Summit in China: Cultivating Unity and Collaboration
- FORVIA H1 2025: Insights on Growth and Strategic Changes
- Roche Advances Alzheimer’s Innovations with Groundbreaking Data
- Innovative Collaboration Between EnduroSat and WISeSat.Space
- Heineken N.V. Achieves Strong Growth in Half-Year Results
- Heineken Holding N.V. Shows Robust Growth in Half-Year Results
- BW Energy Expands Operations with Deepsea Mira Contract
- Bitcoin's Astounding Growth: Chamath's 2013 Call Wins Big
- Heineken N.V. Achieves Strong Half-Year Results for 2025
- FORVIA Reports Strong Half-Year Results and Confirms Guidance
- Heineken Holding N.V. Shows Commitment with Strong Half-Year Performance
- Ambassador Linda Thomas-Greenfield Joins Rendeavour's Vision
- Kalaam Telecom and SecurityHQ Join Forces for Cybersecurity Growth
- Steve Eisman's Take on Opendoor's Soaring Stock Price
- Akeso's Ivonescimab Receives NMPA Approval for Lung Cancer Treatment
- Revolutionizing Pet Eye Care: Dômes Pharma and Fear Free Unite
- Samsung's Bold $16.5 Billion Chip Deal to Compete in Tech Sector
- Exploring the Success of CBD Fair Guangzhou's 2025 Edition
- Economic Impact of Trump's Trade Deal: What Comes Next?
- Antengene Prepares for Major Presentation on ATG-022 at ESMO
- How Japan's $550 Billion Deal Can Boost TSMC's Growth in the US
- Hengrui Pharma and GSK Forge Agreement for Advanced Drug Development
- Time Is Running Out for Solar Tax Credit Savings with All Energy Solar
- US and China Seek Trade Solutions Amid Tariff Tensions
- Introducing Automate's Push PRO: Revolutionary Shade Control
- Exciting Esports World Cup Promotion from JBO Thailand
- Harbour BioMed Unveils Strong Profit Predictions for Future Growth
- Ascletis Begins Significant Obesity Study with ASC30 Drug
- Elpis Biopharmaceuticals Partners with NCCS for Groundbreaking Research
- Perseus Mining's Operational Highlights and Financial Overview
- Shara Magomedov Shines at UFC Night with Epic Victory
- Investors Urged to Participate in Class Action Against Centene
- Exploring America’s Hidden Resource Potential and Technology
- Trump's New Tariff Deal with EU: Impacts and Insights
- Shaquille O'Neal's Hilarious Showdown with Jimmy Kimmel
- Empowering Hims & Hers Health Shareholders: Your Legal Guide
- Public Sentiment on Trump's Tax Cuts: A Closer Look
- Innovative Cooling Solutions Pioneered by i2Cool for a Sustainable Future
- Easterly ROCMuni Fund Class Action: Investor Rights Explained
- Class Action Alert: RxSight Investors Take Action Against Losses
- Investors of iRobot Corporation Urged to Act Before Deadline
- Dustin Moskovitz Expands Asana Holdings with Major Purchase
- Navigating High-Stress Careers: Insights from Executives
- Banco Comercial Português Updates on Share Buy-Back Programme Activity
- Centene Corporation Faces Class Action Over Investor Losses
- Banco Comercial Português (BCP) Shares Buy-Back Program Update
- Insights into Gilead Sciences, Inc. and Recent Developments
- Legal Action Initiated Against Flywire Corporation's Officers
- Replimune Group Faces Legal Action Amid Stock Price Decline
- Investors Seek Clarity on Simulations Plus Financial Concerns